chr6-42178809-GC-TT
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PS1_Very_StrongPM1PP2PP3PP5_Moderate
The NM_001384910.1(GUCA1A):c.359_360delGCinsTT(p.Arg120Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. It is difficult to determine the true allele frequency of this variant because it is of type MNV, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R120H) has been classified as Uncertain significance.
Frequency
Consequence
NM_001384910.1 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| GUCA1A | NM_001384910.1 | c.359_360delGCinsTT | p.Arg120Leu | missense_variant | ENST00000372958.2 | NP_001371839.1 | ||
| GUCA1ANB-GUCA1A | NM_000409.5 | c.359_360delGCinsTT | p.Arg120Leu | missense_variant | NP_000400.2 | |||
| GUCA1ANB-GUCA1A | NM_001319061.2 | c.359_360delGCinsTT | p.Arg120Leu | missense_variant | NP_001305990.1 | |||
| GUCA1ANB-GUCA1A | NM_001319062.2 | c.359_360delGCinsTT | p.Arg120Leu | missense_variant | NP_001305991.1 | 
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD4 genome  
ClinVar
Submissions by phenotype
Cone dystrophy 3    Pathogenic:2 
This variant is interpreted as pathogenic for Cone dystrophy 3, autosomal dominant. The following ACMG Tag(s) were applied: Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium (PM2); Located in a mutational hot spot and/or critical and well-established functional domain (e.g., active site of an enzyme) without benign variation (PM1); Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease (PP1 upgraded to strong); Well-established functional studies show a deleterious effect (PS3). -
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at